Better Therapeutics Inc (BTTX)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track

Stock chart

Ticker: BTTX Exchange: PNK

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Earnings

Value bought

Past 90 days

Value sold

Past 90 days

Net insiders buying

Past 90 days

Trades (buy and sell)

Past 90 days

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2023-07-31	2023-07-27	B Purchase	KARBE FRANK Chief Executive Officer Executive Director	137,005 +46.9% 0.73 USD 100,000	137,005 +46.9%	0.73	USD 100,000
2023-07-31	2023-07-27	B Purchase	PERRY DAVID P Executive Chairman Executive Director Large shareholder	1,233,045 +10.5% 0.73 USD 900,000	1,233,045 +10.5%	0.73	USD 900,000
2023-07-31	2023-07-27	B Purchase	Parker Geoffrey M. Non-Executive Director	685,025 +199.7% 0.73 USD 500,000	685,025 +199.7%	0.73	USD 500,000
2023-07-31	2023-07-27	B Purchase	Granger Elder Non-Executive Director	34,251 +2140.7% 0.73 USD 25,000	34,251 +2140.7%	0.73	USD 25,000
2023-07-31	2023-07-27	B Purchase	Armanino Andrew J. Non-Executive Director	274,010 +60.3% 0.73 USD 200,000	274,010 +60.3%	0.73	USD 200,000
2023-07-31	2023-07-27	B Purchase	Berman Mark A. Chief Medical Officer Officer	54,802 +16.4% 0.73 USD 40,000	54,802 +16.4%	0.73	USD 40,000
2023-05-18	2023-05-16	B Purchase	Granger Elder Non-Executive Director	600 +60.0% 0.87 USD 520	600 +60.0%	0.87	USD 520
2023-04-12	2023-04-10	B Purchase	Armanino Andrew J. Non-Executive Director	303,030 +200.2% 0.83 USD 250,000	303,030 +200.2%	0.83	USD 250,000
2023-04-12	2023-04-10	B Purchase	Parker Geoffrey M. Non-Executive Director	303,030 +757.6% 0.83 USD 250,000	303,030 +757.6%	0.83	USD 250,000
2023-04-12	2023-04-10	B Purchase	KARBE FRANK See Remarks Executive Director	242,424 +484.8% 0.83 USD 200,000	242,424 +484.8%	0.83	USD 200,000
2023-04-12	2023-04-10	B Purchase	PERRY DAVID P See Remarks Executive Director Large shareholder	3,636,364 +inf% 0.83 USD 3,000,000	3,636,364 +inf%	0.83	USD 3,000,000
2023-04-12	2023-04-10	B Purchase	PERRY DAVID P See Remarks Executive Director Large shareholder	1,333,333 +12.7% 0.83 USD 1,100,000	1,333,333 +12.7%	0.83	USD 1,100,000
2022-09-19	2022-09-16	B Purchase	PERRY DAVID P See Remarks Executive Director Large shareholder	39,156 +62.8% 2.07 USD 80,975	39,156 +62.8%	2.07	USD 80,975
2022-09-19	2022-09-15	B Purchase	PERRY DAVID P See Remarks Executive Director Large shareholder	10,844 +21.0% 1.99 USD 21,623	10,844 +21.0%	1.99	USD 21,623
2022-09-15	2022-09-15	B Purchase	KARBE FRANK See Remarks Executive Director	50,000 +inf% 2.09 USD 104,695	50,000 +inf%	2.09	USD 104,695
2022-09-14	2022-09-13	B Purchase	Heinen Mark See Remarks Officer	26,132 +59.6% 1.94 USD 50,696	26,132 +59.6%	1.94	USD 50,696
2022-09-14	2022-09-12	B Purchase	Heinen Mark See Remarks Officer	23,868 +119.3% 1.94 USD 46,304	23,868 +119.3%	1.94	USD 46,304
2022-06-28	2022-06-24	B Purchase	Heinen Mark See Remarks Officer	2,281 +inf% 1.75 USD 4,000	2,281 +inf%	1.75	USD 4,000
2022-06-16	2022-06-14	B Purchase	Armanino Andrew J. Non-Executive Director	15,000 +inf% 1.39 USD 20,846	15,000 +inf%	1.39	USD 20,846
2022-06-14	2022-06-13	B Purchase	Parker Geoffrey M. Non-Executive Director	25,000 +166.7% 1.45 USD 36,183	25,000 +166.7%	1.45	USD 36,183
2022-06-10	2022-06-10	B Purchase	Heinen Mark See Remarks Officer	5,000 +33.3% 1.56 USD 7,800	5,000 +33.3%	1.56	USD 7,800
2022-06-10	2022-06-09	B Purchase	Armanino Andrew J. Non-Executive Director	25,000 +19.8% 1.65 USD 41,355	25,000 +19.8%	1.65	USD 41,355
2022-04-04	2022-03-31	B Purchase	Appelbaum Kevin J Chief Executive Officer Executive Director Large shareholder	2,500 +66.7% 1.97 USD 4,921	2,500 +66.7%	1.97	USD 4,921
2022-04-04	2022-03-31	B Purchase	Heinen Mark See Remarks Officer	5,000 +50.0% 1.98 USD 9,900	5,000 +50.0%	1.98	USD 9,900
2021-12-23	2021-12-21	B Purchase	LAVIZZO-MOUREY RISA J Non-Executive Director	10,000 +inf% 4.60 USD 46,000	10,000 +inf%	4.60	USD 46,000
2021-12-22	2021-12-20	B Purchase	Appelbaum Kevin J Chief Executive Officer Executive Director Large shareholder	1,000 +36.4% 4.60 USD 4,600	1,000 +36.4%	4.60	USD 4,600
2021-12-17	2021-12-15	B Purchase	Appelbaum Kevin J Chief Executive Officer Executive Director Large shareholder	750 +37.5% 4.71 USD 3,530	750 +37.5%	4.71	USD 3,530
2021-12-15	2021-12-15	B Purchase	Heinen Mark See Remarks Officer	2,333 +30.4% 4.70 USD 10,953	2,333 +30.4%	4.70	USD 10,953
2021-12-16	2021-12-14	B Purchase	Parker Geoffrey M. Non-Executive Director	20,000 +60.0% 4.94 USD 98,800	20,000 +60.0%	4.94	USD 98,800
2021-12-15	2021-12-14	B Purchase	Heinen Mark See Remarks Officer	500 +7.0% 5.44 USD 2,721	500 +7.0%	5.44	USD 2,721
2021-12-15	2021-12-13	B Purchase	Heinen Mark See Remarks Officer	500 +7.5% 5.45 USD 2,725	500 +7.5%	5.45	USD 2,725
2021-12-15	2021-12-13	B Purchase	Armanino Andrew J. Non-Executive Director	21,000 +32.1% 5.48 USD 115,067	21,000 +32.1%	5.48	USD 115,067
2021-12-14	2021-12-10	B Purchase	Appelbaum Kevin J Chief Executive Officer Executive Director Large shareholder	1,000 +100.0% 5.98 USD 5,975	1,000 +100.0%	5.98	USD 5,975
2021-12-07	2021-12-03	B Purchase	Granger Elder Non-Executive Director	1,000 +inf% 6.66 USD 6,660	1,000 +inf%	6.66	USD 6,660
2021-12-06	2021-12-03	B Purchase	Appelbaum Kevin J Chief Executive Officer Executive Director Large shareholder	500 +100.0% 6.43 USD 3,213	500 +100.0%	6.43	USD 3,213
2021-12-06	2021-12-02	B Purchase	Appelbaum Kevin J Chief Executive Officer Executive Director Large shareholder	500 +inf% 6.84 USD 3,420	500 +inf%	6.84	USD 3,420
2021-12-01	2021-11-29	B Purchase	Armanino Andrew J. Non-Executive Director	17,000 +35.2% 6.96 USD 118,320	17,000 +35.2%	6.96	USD 118,320
2021-11-01	2021-10-28	B Purchase	PERRY DAVID P See Remarks Executive Director Large shareholder	200,000 +1.9% 10.00 USD 2,000,000	200,000 +1.9%	10.00	USD 2,000,000
2021-11-01	2021-05-26	B Purchase	PERRY DAVID P See Remarks Executive Director Large shareholder	20,000 +63.4% 9.95 USD 199,000	20,000 +63.4%	9.95	USD 199,000
2021-11-01	2021-05-24	B Purchase	PERRY DAVID P See Remarks Executive Director Large shareholder	8,000 +34.0% 9.94 USD 79,520	8,000 +34.0%	9.94	USD 79,520
2021-11-01	2021-05-21	B Purchase	PERRY DAVID P See Remarks Executive Director Large shareholder	8,000 +51.5% 9.95 USD 79,600	8,000 +51.5%	9.95	USD 79,600
2021-11-01	2021-05-14	B Purchase	PERRY DAVID P See Remarks Executive Director Large shareholder	3,060 +24.5% 9.93 USD 30,386	3,060 +24.5%	9.93	USD 30,386
2021-11-01	2021-05-13	B Purchase	PERRY DAVID P See Remarks Executive Director Large shareholder	7,000 +127.8% 9.93 USD 69,510	7,000 +127.8%	9.93	USD 69,510
2021-11-01	2021-05-04	B Purchase	PERRY DAVID P See Remarks Executive Director Large shareholder	3,476 +173.8% 9.93 USD 34,517	3,476 +173.8%	9.93	USD 34,517
2021-11-01	2021-04-30	B Purchase	PERRY DAVID P See Remarks Executive Director Large shareholder	2,000 +inf% 9.95 USD 19,900	2,000 +inf%	9.95	USD 19,900
2021-04-09	2021-04-07	S Sale	Liu Suying Chief Executive Officer Executive Director Large shareholder	200,000 -12.7% 9.00 USD 1,800,000	200,000 -12.7%	9.00	USD 1,800,000
2021-01-19	2021-01-14	B Purchase	Liu Dong Chief Financial Officer Executive Director Large shareholder	7,500 +0.5% 10.00 USD 75,000	7,500 +0.5%	10.00	USD 75,000
2021-01-19	2021-01-14	B Purchase	Liu Suying Chief Executive Officer Executive Director Large shareholder	7,500 +0.5% 10.00 USD 75,000	7,500 +0.5%	10.00	USD 75,000
2021-01-19	2021-01-14	B Purchase	Mountain Crest Capital LLC Large shareholder	7,500 +0.5% 10.00 USD 75,000	7,500 +0.5%	10.00	USD 75,000
2021-01-14	2021-01-12	B Purchase	Liu Suying Chief Executive Officer Executive Director Large shareholder	135,000 +9.4% 10.00 USD 1,350,000	135,000 +9.4%	10.00	USD 1,350,000
2021-01-14	2021-01-12	B Purchase	Liu Dong Chief Financial Officer Executive Director Large shareholder	135,000 +9.4% 10.00 USD 1,350,000	135,000 +9.4%	10.00	USD 1,350,000
2021-01-14	2021-01-12	B Purchase	Mountain Crest Capital LLC Large shareholder	135,000 +9.4% 10.00 USD 1,350,000	135,000 +9.4%	10.00	USD 1,350,000

Better Therapeutics Inc (BTTX)

Track

Stock chart

Earnings

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Transactions

Insider

Sort by